close
2014
DOI: 10.1016/j.vaccine.2014.04.055
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Effectiveness of typhoid vaccination in US travelers

Abstract: Typhoid vaccination is recommended in the United States before travel to countries where typhoid fever is endemic, though little information is available on its effectiveness in travelers. We estimated typhoid vaccination effectiveness (VE) by comparing vaccination status in cases of typhoid fever and paratyphoid fever (Salmonella Paratyphi A infection, against which typhoid vaccine offers no protection) reported in the United States. We included travelers to Southern Asia and excluded persons <2 years old and… Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
23
3
2
0

Citation Types

0
10
0
1

Year Published

Range
2015
2015
2026
2026

Publication Types

Select...
20
7
1

Relationship

2
26

Authors

Journals

citations

Cited by 28 publications

(11 citation statements)
references

References 12 publications

0
10
0
1
Order By: Relevance
How this paper cites the one you are viewing
“…Three currently available typhoid vaccines are recommended by the WHO: an oral vaccine based on a live attenuated mutant strain of STY Ty21a (Ty21a), the injectable Vi capsular polysaccharide (ViCPS) vaccine and the typhoid conjugate vaccine (TCV) (http://www.who.int/immunization/policy/position_papers/typhoid/en/). However, these Typhi vaccines do not provide protection against paratyphoid fever caused by SPTA [44], and hence, a vaccine that protects against typhoid and paratyphoid fever would be of high value. When selecting antigens for developing new diagnostics or vaccines for both STY and SPTA, one should take into account that although encoded in both serovars, membrane proteins can be differentially expressed between both serovars and this should be tested in vitro and in vivo.…”
Section: Discussion
mentioning
confidence: 99%